Biohit Oyj · Helsinki Finland
Key Biohit Oyj Financials
| Company Type | Public - Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $53.1 |
| 2010 Employees | 412 |
Biohit Oyj Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 53.1 | 50.7 | 49.1 |
| Cost of Goods Sold | 10.3 | 9.3 | 9.4 |
| Gross Profit | 42.8 | 41.4 | 39.6 |
| Gross Profit Margin | 80.6% | 81.7% | 80.8% |
| SG&A Expense | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | 0.7 | 1.7 | 1.9 |
| Operating Margin | 1.3% | 3.4% | 3.8% |
| Nonoperating Income | 0.0 | 0.0 | 0.0 |
| Nonoperating Expenses | (0.2) | (0.7) | (0.4) |
| Income Before Taxes | 0.5 | 1.0 | 1.4 |
| Income Taxes | 0.4 | 0.4 | 0.1 |
| Net Income After Taxes | 0.1 | 0.6 | 1.3 |
| Continuing Operations | 0.1 | 0.6 | 1.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 0.1 | 0.6 | 1.3 |
| Total Net Income | 0.1 | 0.6 | 1.3 |
| Net Profit Margin | 0.2% | 1.1% | 2.6% |
| Diluted EPS from Total Net Income | 0.01 | 0.04 | 0.10 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Biohit Oyj Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 2.2 | 2.3 | 1.8 |
| Net Receivables | -- | -- | -- |
| Inventories | 6.9 | 7.4 | 8.1 |
| Other Current Assets | 11.0 | 10.4 | 10.3 |
| Total Current Assets | 20.1 | 20.1 | 20.2 |
| Net Fixed Assets | 8.7 | 9.3 | 9.1 |
| Other Noncurrent Assets | 10.2 | 9.9 | 8.9 |
| Total Assets | 38.9 | 39.3 | 38.2 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 2.5 | 2.0 | 1.9 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 6.8 | 12.3 | 6.3 |
| Total Current Liabilities | 9.2 | 14.3 | 8.2 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 12.5 | 6.7 | 12.4 |
| Total Liabilities | 21.7 | 21.0 | 20.6 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 17.2 | 18.3 | 17.6 |
| Total Equity | 17.2 | 18.3 | 17.6 |
| Shares Outstanding (thou.) | 12,937.6 | 12,937.6 | 12,937.6 |
All amounts in millions of US Dollars except per share amounts.
Biohit Oyj Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 3 | 4 | 2 |
| Net Investing Cash Flow | (2.5) | (2.7) | (1.1) |
| Net Financing Cash Flow | (0.1) | (0.9) | (0.4) |
| Net Change in Cash | (0.0) | 0.4 | 0.2 |
| Depreciation & Amortization | |||
| Capital Expenditures | (2.4) | (2.9) | (1.7) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.